| 1 |
Martínez-Montoro JI, Núñez-Sánchez MÁ, Martinez-Sanchez MA, Balaguer-Román A, Fernández-Ruiz VE, Ferrer-Gómez M, Sledzinski T, Frutos MD, Fernández-García JC, Mika A, Ramos-Molina B. Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case-control study. Obesity (Silver Spring) 2023. [PMID: 36876627 DOI: 10.1002/oby.23711] [Reference Citation Analysis]
|
| 2 |
Nagase Y, Satoh T, Shigetome K, Tokumaru N, Matsumoto E, Yamada KD, Imafuku T, Watanabe H, Maruyama T, Ogata Y, Yoshida M, Saruwatari J, Oniki K. Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease. Nutrients 2023;15. [PMID: 36839168 DOI: 10.3390/nu15040809] [Reference Citation Analysis]
|
| 3 |
Chu DT, Nguyen TL. Frizzled receptors and SFRP5 in lipid metabolism: Current findings and potential applications. Prog Mol Biol Transl Sci 2023;194:377-93. [PMID: 36631199 DOI: 10.1016/bs.pmbts.2022.06.025] [Reference Citation Analysis]
|
| 4 |
Munkong N, Somnuk S, Jantarach N, Ruxsanawet K, Nuntaboon P, Kanjoo V, Yoysungnoen B. Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice. Nutrients 2023;15. [PMID: 36615905 DOI: 10.3390/nu15010246] [Reference Citation Analysis]
|
| 5 |
Xie F, Xu H, Zhang J, Liu X, Kou B, Cai M, Wu J, Dong J, Meng Q, Wang Y, Chen D, Zhang Y. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.974872] [Reference Citation Analysis]
|
| 6 |
Segatto M, Cutone A, Pallottini V. Fat Checking: Emerging Role of Lipids in Metabolism and Disease. Int J Mol Sci 2022;23. [PMID: 36430317 DOI: 10.3390/ijms232213842] [Reference Citation Analysis]
|
| 7 |
Hou D, Tang J, Huan M, Liu F, Zhou S, Shen Q. Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice. Food Science and Human Wellness 2022;11:1259-72. [DOI: 10.1016/j.fshw.2022.04.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Mikłosz A, Nikitiuk BE, Chabowski A. Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand? Obes Rev 2022;23:e13413. [PMID: 34985174 DOI: 10.1111/obr.13413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 9 |
Hliwa A, Mika A, Sledzinski M, Laski D, Ramos-molina B, Sledzinski T. Changes in the Serum Fatty Acid Profile After Anhepatic Phase of Orthotopic Liver Transplantation Procedure. Front Physiol 2022;13:817987. [DOI: 10.3389/fphys.2022.817987] [Reference Citation Analysis]
|
| 10 |
Martinou E, Pericleous M, Stefanova I, Kaur V, Angelidi AM. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics (Basel) 2022;12:407. [PMID: 35204498 DOI: 10.3390/diagnostics12020407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 11 |
Liu S, Weng R, Gu X, Li L, Zhong Z. Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case-control study. J Clin Lab Anal 2021;:e24061. [PMID: 34664321 DOI: 10.1002/jcla.24061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
